Canary Capital files for staked Injective ETF – Can INJ target $16 next?
The post Canary Capital files for staked Injective ETF – Can INJ target $16 next? appeared on BitcoinEthereumNews.com. Key Takeaways Canary Capital files for the first-ever Injective staking ETF. The DEX volume has also increased in the last 24 hours, while TVL almost hit 2025 highs. But how high can INJ rise after these triggers? Injective [INJ] rose by about 8% in the last 24 hours as of press time, with an unlocked market cap of $1.45 billion as per CoinMarketCap. Meanwhile, the AI crypto coin is getting more exposure in the U.S. market. Canary Capital files for Injective staking ETF Canary Capital filed for the first-ever Injective staking ETF in Delaware, as reported on X (formerly Twitter), with the product set to contribute to network security. Earlier on, 21Shares’ AINJ ETF in Europe had an impact on demand, which suggested the U.S. market could have an even larger one following its size. Source: X The SEC has yet to confirm receipt of the Injective ETF filing. Once acknowledged, it will announce key dates for further updates. This decision could shape Injective’s long-term trajectory, especially as ETFs become a popular gateway for crypto exposure. The proposed Canary Staked INJ ETF offers both price exposure and staking rewards, making it a unique tool for investors seeking regulated access to decentralized finance Will the reversal pattern hold? Meanwhile, the price action of Injective broke above a massive inverted head-and-shoulders pattern, which could be a sign the trend had shifted. After INJ successfully retested the breakout with a double bottom, the price surged up to $15, at press time. As INJ traded in a key zone between the $14-$16 price range, its reaction here could define its short-term outlook as the ETF hype drives price. Failure to thrust past $16 and sustaining to stay above in the current sentiment could result in struggles to proceed higher. Source: TradingView Still, the zone…
The post Canary Capital files for staked Injective ETF – Can INJ target $16 next? appeared on BitcoinEthereumNews.com.
Key Takeaways Canary Capital files for the first-ever Injective staking ETF. The DEX volume has also increased in the last 24 hours, while TVL almost hit 2025 highs. But how high can INJ rise after these triggers? Injective [INJ] rose by about 8% in the last 24 hours as of press time, with an unlocked market cap of $1.45 billion as per CoinMarketCap. Meanwhile, the AI crypto coin is getting more exposure in the U.S. market. Canary Capital files for Injective staking ETF Canary Capital filed for the first-ever Injective staking ETF in Delaware, as reported on X (formerly Twitter), with the product set to contribute to network security. Earlier on, 21Shares’ AINJ ETF in Europe had an impact on demand, which suggested the U.S. market could have an even larger one following its size. Source: X The SEC has yet to confirm receipt of the Injective ETF filing. Once acknowledged, it will announce key dates for further updates. This decision could shape Injective’s long-term trajectory, especially as ETFs become a popular gateway for crypto exposure. The proposed Canary Staked INJ ETF offers both price exposure and staking rewards, making it a unique tool for investors seeking regulated access to decentralized finance Will the reversal pattern hold? Meanwhile, the price action of Injective broke above a massive inverted head-and-shoulders pattern, which could be a sign the trend had shifted. After INJ successfully retested the breakout with a double bottom, the price surged up to $15, at press time. As INJ traded in a key zone between the $14-$16 price range, its reaction here could define its short-term outlook as the ETF hype drives price. Failure to thrust past $16 and sustaining to stay above in the current sentiment could result in struggles to proceed higher. Source: TradingView Still, the zone…
What's Your Reaction?
